Lovisa Afzelius, Co-Founder and Founding CEO, Metaphore Biotechnologies, and Uli Stilz, Head of Novo Nordisk’s Bio Innovation Hub, join Paul Biondi, Flagship General Partner and President of Pioneering Medicines, for a discussion about the research collaboration between the three companies to advance therapeutic options for people living with obesity, a condition which presents a serious disease burden with opportunities for new and potentially highly efficacious and durable medicines. More from Flagship @ JPM2025 here.
Pioneering Partnerships: Developing Next Generation Therapeutics for Obesity Management
More from:
Human Health

Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK

Pioneering Partnerships: Accelerating our Collaboration with Pfizer

Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies

Halting the Trajectory of Disease with Preemptive Health

AI in Action
